Healthcare & Life Sciences
Lilac Therapeutics
United Stateswww.lilactx.com
Lilac Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
2020
Founded
1
Investors
About Lilac Therapeutics
Lilac Therapeutics is a startup founded in 2020 based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Lilac Therapeutics is a clinical-stage company developing LLX-424, a small molecule glycolate oxidase inhibitor designed to prevent recurrent calcium oxalate kidney stones by reducing urinary oxalate levels.
Explore Lilac Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.